9 studies were found.

1.		Recruiting	Gemcitabine and Docetaxel to Treat Bone and Soft Tissue Cancers Conditions: Osteosarcoma; Sarcoma, Ewing's; Chondrosarcoma
2.		Not yet recruiting	Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma Conditions: recurrent tumors of the Ewing's family; Chondrosarcoma; recurrent osteosarcoma
3.		Not yet recruiting	Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer Conditions: Cachexia; Cancer; Pain
4.		Recruiting	Alanosine in Treating Patients With Cancer Conditions: Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma; thorax and respiratory cancer
5.		Recruiting	Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Condition: Cancer
6.		Recruiting	Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Conditions: childhood rhabdomyosarcoma; childhood soft tissue sarcoma; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma
7.		Recruiting	Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Condition: Cancer
8.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma Condition: Cancer
9.		Recruiting	Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Conditions: bone marrow ablation; Cancer